The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title | Intervention | Sponsor | Status Sort descending |
|---|---|---|---|
| Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study | Educational Intervention, FitBit, Goal Setting, Health Promotion and Education, Media Intervention, Telephone-Based Intervention | Children's Oncology Group | Active, not recruiting |
| Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors | Carvedilol, Laboratory Biomarker Analysis, Pharmacogenomic Study, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery | Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | SWOG Cancer Research Network | Active, not recruiting |
| Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection | Axillary Lymph Node Dissection, Isosulfan Blue, Mapping, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| S0820, Adenoma and Second Primary Prevention Trial | Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo | SWOG Cancer Research Network | Active, not recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer | Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation | Questionnaire | Eastern Cooperative Oncology Group | Active, not recruiting |
| Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer | Carboplatin, Comprehensive Geriatric Assessment, Pembrolizumab, Pemetrexed, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer | Chemotherapy, Functional Assessment, Questionnaire Administration | SWOG Cancer Research Network | Active, not recruiting |
| Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States | Electronic Health Record Review, Interview, Survey Administration | Children's Oncology Group | Active, not recruiting |
Publications
News and Events
AACR Announces 2024 Distinguished Public Service Award Recipients
Date Posted: February 19, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023
Worta McCaskill-Stevens, M.D.: An Appreciation for a Driving Force in Cancer Prevention and Addressing Cancer Disparities
Date Posted: November 17, 2023
Acting Chief of Community Oncology and Prevention Trials Research Group Named
Date Posted: November 1, 2023
NCORP Director Worta McCaskill-Stevens Honored with Career Development Award in Her Name
Date Posted: August 24, 2023